Peritoneal Cancer
A Phase 1b, Multicenter Study to Determine the Dose, Safety, Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selected Anti-Cancer Treatment Regimens in Patients with Selected Advanced Solid Tumors.(950P1V02)
- Details
ClinicalTrials.gov ID:
NCT03872947
Diagnosis Type:
NA
USOR Number:
- Address
603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206